✦ LIBER ✦

NICE recommends refund scheme for bortezomib in MM

Book ID: 120847124
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715920-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib approved for previously untre

Bortezomib approved for previously untreated MM in EU.

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

NICE recommendation for entecavir in hep

NICE recommendation for entecavir in hep B

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Bortezomib gets priority review for use

Bortezomib gets priority review for use in newly diagnosed MM

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Trends in procedures for infertility and

Trends in procedures for infertility and caesarean sections: was NICE disinvestment guidance implemented? NICE recommendation reminders

✍ Charlotte A Chamberlain, Richard M Martin, John Busby, Rebecca Gilbert… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 315 KB

NICE recommendations for the prevention

NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women

✍ Pierre D. Delmas; Ethel S. Siris 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Valuing health technologies at nice: rec

Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA

✍ Dana Goldman; Darius Lakdawalla; Tomas J. Philipson; Wesley Yin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Pricing, reimbursements and coverage decisions for medical innovations and services are complex. In many countries, valuing medical technologies is the responsibility of national health-care systems that strive for distributive efficiency under fiscal constraints on medical spending. In the UK, the